Search clinical trials for: Chewing Ticagrelor

Total 762 results

Region Skane
AstraZeneca; IHF GmbH - Institut für Herzinfarktforschung; Hippocrates Research; IRW consulting...

Withdrawn

Study in Diabetes Mellitus Patients Without Prior Myocardial Infarction or Stroke Undergoing Elective Percutaneous Coronary Intervention. (AUGEAS)

Diabetes Mellitus | Microvascular Coronary Artery Disease
Hospital Clinic of Barcelona
AstraZeneca

Completed

TIcaGrEloR and ABSORB Bioresorbable Vascular Scaffold Implantation for Recovery of Vascular Function After Successful Chronic Total Occlusion Recanalization (TIGER-BVS)

Patients Who Are Scheduled to Undergo a PCI (Percutaneous Coronary Intervention) for CTO (Chronic Total Occlusion)

Spain
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management (TICA KOREA)

Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Angina Pectoris | Acute Coronary Syndrome

Korea, Republic of
Gordon Bernard
AstraZeneca

Terminated

Ticagrelor in Severe Community Acquired Pneumonia (TCAP)

Community Acquired Pneumonia, Severe

United States
Yonsei University

Terminated

Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome

Acute Coronary Syndrome | Acute Myocardial Infarction | Unstable Angina (Intermediate Coronary Syndrome)

Korea, Republic of
Guangdong Provincial People's Hospital

Completed

The Impact of Genotype on Pharmacokinetics and Antiplatelet Effects of Ticagrelor in Healthy Chinese (IGPPT)

Healthy
Kiyuk Chang
AstraZeneca

Unknown

Effect of Ticagrelor Versus Clopidogrel on Endothelial Dysfunction and Vascular Inflammation

Endothelial Dysfunction | Vascular Inflammation

Korea, Republic of
Chinese PLA General Hospital

Unknown

Effects of Ticagrelor on No-reflow in Patients With Acute ST-segment Elevation Myocardial Infarction

Cardiovascular Diseases

China
Karolinska University Hospital
AstraZeneca

Completed

Ticagrelor Pharmacokinetics in NSTEMI

Myocardial Infarction

Sweden
AstraZeneca

Completed

Ad Hoc Percutaneous Coronary Intervention Study in Acute Coronary Syndrome Patients

Acute Coronary Syndrome

United States
Inha University Hospital

Completed

Comparison of Clopidogrel and Ticagrelor on Microvascular Dysfunction in ST-Segment Elevation Myocardial Infarction

ST Segment Elevation Myocardial Infarction | Non-ST Segment Elevation Myocardial Infarction

Korea, Republic of
Fujian Medical University

Recruiting

Optimized Antiplatelet Therapy on the Prognosis of ACS Patients With Non-predominant Coronary Artery Disease After PCI

Acute Coronary Syndrome | Percutaneous Coronary Intervention

China
Harbin Medical University
LanZhou University; Hebei General Hospital; The First Hospital of Jilin University and other collaborators

Active, not recruiting

EROSION II: OCT Guided PPCI in STEMI

ST-segment Elevation Myocardial Infarction

China
Fondazione per la Ricerca Ospedale Maggiore

Completed

ADHerence of ticagrelOr in Real World Patients With aCute Coronary Syndrome (AD-HOC)

Acute Coronary Syndrome
Medstar Health Research Institute
AstraZeneca

Completed

NIRS Ticagrelor Evaluation

Coronary Artery Disease
Hellenic Cardiovascular Research Society
AstraZeneca

Completed

Compare Ticagrelor vs Clopidogrel on the Reduction of Arterial Stiffness and Wave Reflectionsin Patients With CAD. (NOVELTY)

Coronary Artery Disease

Greece
Kafrelsheikh University

Recruiting

Ticagrelor Versus Cilostazol in Large-vessel Ischemic Stroke

Ischemic Stroke

Egypt
University of Florida

Recruiting

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI (TAILOR BLEED)

Coronary Artery Disease

United States
McGill University Health Centre/Research Institute...
Canadian Institutes of Health Research (CIHR)

Completed

Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes (TC4)

Acute Coronary Syndrome

Canada
Jiangsu HengRui Medicine Co., Ltd.

Completed

To Evaluate the Safety and Tolerability of Combined Administration of SHR2285 Tablets With Aspirin, Clopidogrel or Ticagrelor in Healthy Subjects

Thrombosis

China
Beijing Neurosurgical Institute

Completed

Application of Platelet Function Test in Prevention of Ischemic Events After Stent Placement in Intracranial Aneurysms (APISIA Trail)

Stents | Unruptured Intracranial Aneurysm | Antiplatelet Drugs

China
Radboud University Medical Center

Completed

Ticagrelor in Human Endotoxemia Response to Human Endotoxemia

Endotoxemia

Netherlands
Liverpool University Hospitals NHS Foundation Trust
Liverpool Heart and Chest Hospital NHS Foundation Trust; Countess of Chester... and other collaborators

Completed

The Risk of Major Bleeding With Novel Anti-platelets: A Comparison of Ticagrelor With Clopidogrel in a Real World Population of 5000 Patients Treated for Acute Coronary Syndrome (ROBOT-ACS)

Bleeding | Acute Coronary Syndrome | Ticagrelor | Clopidogrel | Novel Anti-platelets

United Kingdom
Aurora Health Care

Completed

Chewed Versus Integral Pill of Ticagrelor

Percutaneous Coronary Intervention

United States
J.M. ten Berg
AstraZeneca

Unknown

The Effect Of Ticagrelor On Saphenous Vein Graft Patency In Patients Undergoing Coronary Artery Bypass Grafting Surgery (POPular CABG)

Coronary Artery Disease | Acute Coronary Syndrome | Stable Angina

Netherlands
IHF GmbH - Institut für Herzinfarktforschung

Completed

Real Life Long-term Adherence to Ticagrelor After PCI for Acute Coronary Syndromes (Real-TICA)

Acute Coronary Syndrome (ACS)

Germany
AstraZeneca

Completed

A Pharmacodynamic Study With Ticagrelor in African American Patients

Stable Coronary Artery Disease

United States
AstraZeneca

Completed

Study to Assess the Pharmacokinetics of AZD6140 After Single Dose in Healthy Japanese Male Volunteers

Healthy

Japan
Assistance Publique Hopitaux De Marseille

Recruiting

TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome. (TROUPER)

Acute Coronary Syndrome

France
University Hospitals Cleveland Medical Center

Completed

Inflammation and Thrombosis in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement (TAVR)

Inflammation | Thrombosis | Aortic Stenosis

United States
University of Southern California

Completed

Switch to Ticagrelor in Critical Limb Ischemia Anti-platelet Study (STT-CLIPS)

Critical Limb Ischemia

United States
Dong-A University
AstraZeneca; Biotronik SE & Co. KG

Completed

Comparing Ticagrelor Versus Clopidogrel on Microcirculation (PLEIO)

Acute Coronary Syndrome

Korea, Republic of
University of Patras
AstraZeneca

Completed

A Randomized, Pharmacodynamic Comparison of Low Dose Ticagrelor to Clopidogrel in Patients With Prior Myocardial Infarction (ALTIC)

Myocardial Infarction | Coronary Artery Disease | Diabetes Mellitus | Renal Disease

Greece
Taipei Veterans General Hospital, Taiwan

Unknown

Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCI

Acute Coronary Syndrome

Taiwan
CHEOL WHAN LEE, M.D., Ph.D
AstraZeneca; CardioVascular Research Foundation, Korea

Completed

Comparison of Clopidogrel Versus Ticagrelor Therapy for Atherosclerotic Plaque Inflammation

Plaque, Atherosclerotic

Korea, Republic of
AstraZeneca

Completed

A Pharmacodynamic Study With Ticagrelor in Hispanic Patients

Stable Coronary Artery Disease

United States
Brown University

Unknown

Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer

Liver Cancer | Gallbladder Cancer | Extrahepatic Bile Duct Cancer

United States
AstraZeneca

Completed

Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy Volunteers

Renal Impairment

United States
AstraZeneca

Completed

An Open-Label, Single and Multiple Dose Pharmacokinetic Study of 90 mg and 180 mg Doses of AZD6140 in Healthy Volunteers

Pharmacokinetics

China
Millennium Pharmaceuticals, Inc.

Completed

Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma

Lymphoma | Multiple Myeloma | Hodgkin Lymphoma | Hematologic Malignancies

United States
Hospital de Clinicas de Porto Alegre

Unknown

Prolonged Infusion Cefepime and Nosocomial Infections (PICNIC)

Urinary Tract Infection | Respiratory Tract Infection

Brazil
University of Maryland, Baltimore

Completed

CES1 Crossover Trial of Clopidogrel and Ticagrelor

Myocardial Infarction | Thrombosis | Platelet Dysfunction

United States
Universiti Sains Malaysia

Completed

Impact of CYP2C19 Genotype-guided Clopidogrel and Ticagrelor Treatment on Platelet Function Test and Metabolomics Profile

Coronary Artery Disease (CAD)

Malaysia
Spanish Society of Cardiology
AstraZeneca

Unknown

Comparison of TIcagrelor and Clopidogrel in Patients With Coronary Artery diseaSe and Type 2 Diabetes Mellitus (TICS-DM) (TICS-DM)

Coronary Artery Disease | Diabetes Mellitus. Type 2

Spain
Jinan Central Hospital

Unknown

Comparison of Ticagrelor And Clopidogrel on Inflammatory Biomarkers And Vascular Endothelial Function (TIGERCAVE)

ST-Segment Elevation Myocardial Infarction

China
First Hospital of China Medical University
AstraZeneca

Unknown

Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI

Myocardial Infarction | No-Reflow Phenomenon

China
University of Patras

Completed

Ticagrelor Versus Prasugrel in Acute Coronary Syndromes After Percutaneous Coronary Intervention

Coronary Artery Disease | Acute Coronary Syndrome

Greece
Yonsei University

Not yet recruiting

Dual Antiplatelet Therapy in Patients With Clopidogrel Resistance Following Off-Pump Coronary Artery Bypass

Multi Vessel Coronary Artery Disease

Korea, Republic of
University of Florida
AstraZeneca

Completed

Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCI (OPTIMUS-6)

Coronary Artery Disease | Diabetes Mellitus, Type 2

United States
Medical University of Warsaw
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Completed

Antiplatelet Therapy Effect on Extracellular Vesicles in Acute Myocardial Infarction (AFFECT EV)

Myocardial Infarction

Netherlands, Poland

Search clinical trials for: Chewing Ticagrelor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations